Jinxin Fertility

What Jinxin Fertility does

Jinxin Fertility (锦欣生殖) is a Hong Kong-listed (HK1951) fertility and reproductive healthcare services company headquartered in Chengdu, Sichuan Province, China. It operates a network of ten wholly-owned medical facilities providing assisted reproductive technology (ART) services — principally IVF and ICSI — alongside obstetrics and gynecology care. The group combines a domestic Chinese footprint spanning Sichuan, Guangdong, Hubei, and Yunnan provinces with international facilities in Hong Kong, the United States (HRC Fertility), and Indonesia (MorulaIVF), and includes an integrated traditional Chinese medicine and Western medicine obstetrics facility in Wuhan.

Name

Jinxin Fertility

Legal name

Jinxin Fertility Limited (锦欣生殖医疗管理有限公司)

Website

https://jxr-fertility.com

Company type

Public

Founded year

2018

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Jinxin Fertility (锦欣生殖) is a Hong Kong-listed fertility and reproductive healthcare company operating ten wholly-owned hospitals and clinics across China, Hong Kong, the United States (HRC), and Indonesia (MorulaIVF), serving couples and individuals seeking IVF, ICSI, and obstetrics/gynecology services.

Ownership category

akta.pro rank

Product category

Fertility and Reproductive Healthcare Services

NAICS

Family Planning Centers (621410)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093), Services-Hospitals (8060)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industry

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

Keywords

• Fertility treatments
• Assisted reproductive technology
• IVF services
• Obstetrics and gynecology
• Reproductive medicine

Headquarters

HQ city

Chengdu

HQ country

China

HQ region

Asia

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medical Services Revenue: Revenue generated from fertility treatments, IVF procedures, and related medical services across its network of hospitals and clinics in China, Hong Kong, USA, and Indonesia.

Distribution channels1 record

Marketing channels1 record

Core offering

Jinxin Fertility operates a network of hospitals and clinics providing assisted reproductive technology (ART) services, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and related fertility treatments. The company delivers these services through wholly-owned subsidiary facilities across mainland China, Hong Kong, the United States (HRC Fertility), and Indonesia (Morula IVF), supplemented by obstetrics, gynecology, and integrative traditional Chinese and Western medicine care.

Product overview

Jinxin Fertility is a fertility and reproductive healthcare services company operating a network of hospitals and medical facilities across China, Hong Kong, the United States, and Indonesia. The company operates through its portfolio of subsidiary hospitals including specialized women's and children's hospitals, obstetrics and gynecology hospitals, and international fertility clinics. The network comprises 10 facilities including Sichuan Jinxi Xinan Women and Children Hospital (Jingxiu and Bisheng campuses), Shenzhen Zhongshan Obstetrics and Gynecology Hospital, Wuhan Jinxin Integrated TCM and Western Medicine Obstetrics and Gynecology Hospital, Yunnan Jinxin Jiuzhou Hospital, Kunming Jinxin HeWanjia Obstetrics and Gynecology Hospital, Hong Kong GanEn Medical, Chengdu Jinjiang District Maternal and Child Health Hospital Reproductive Medicine Center, US HRC Fertility, and Indonesia Morula IVF.

Differentiator

Problem solved

Functional benefit

Products and services

• Sichuan Jinxin Xinan Women and Children's Hospital - Jingxiu Campus (四川锦欣西囡妇女儿童医院静秀院区) Specialized women's and children's hospital in Chengdu, China, providing fertility and reproductive healthcare services to individuals and couples.
• Sichuan Jinxin Xinan Women and Children's Hospital - Bisheng Campus (四川锦欣西囡妇女儿童医院毕昇院区) Specialized women's and children's hospital branch in Chengdu, China, providing fertility and reproductive healthcare services.
• Shenzhen Zhongshan Obstetrics and Gynecology Hospital (深圳中山妇产医院) Maternity and gynecological hospital in Shenzhen, China, offering reproductive healthcare services including fertility treatments.
• Wuhan Jinxin Integrated Traditional Chinese and Western Medicine Obstetrics and Gynecology Hospital (武汉锦欣中西医结合妇产医院) Hospital in Wuhan, China, combining traditional Chinese medicine and Western medicine approaches for obstetrics, gynecology, and fertility services.
• Yunnan Jinxin Jiuzhou Hospital (云南锦欣九洲医院) Hospital in Yunnan Province, China, providing fertility and reproductive healthcare services.
• Kunming Jinxin HeWanjia Obstetrics and Gynecology Hospital (昆明锦欣和万家妇产医院) Maternity hospital in Kunming, China, offering obstetrics and gynecology healthcare services including fertility treatments.
• Hong Kong Grateful Medical (香港感恩医疗) Medical facility in Hong Kong providing fertility-related healthcare services to patients seeking ART treatments.
• Chengdu Jinjiang District Maternal and Child Health Hospital Reproductive Medicine Center (成都市锦江区妇幼保健院生殖医学中心) Reproductive medicine center under the Jinjiang District Maternal and Child Health Hospital in Chengdu, China, providing fertility and reproductive services.
• HRC Fertility (美国HRC) HRC Fertility, an acquired fertility clinic in the United States (Los Angeles area) providing assisted reproductive technology services including IVF.
• Morula IVF Indonesia (印尼MorulaIVF) Morula IVF Indonesia, a fertility clinic in Jakarta, Indonesia, offering IVF and reproductive healthcare services.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves6 records

Expansion highlights5 records

Direct peers

• Virtus Health: ASX-listed fertility clinic operator in Australia and Ireland providing IVF and ART services through a network of owned clinics. Highly comparable to Jinxin as a publicly listed, multi-site fertility services platform.
• Monash IVF: ASX-listed provider of IVF and reproductive health services across Australia and select international markets. Directly comparable as a publicly listed pure-play fertility clinic operator with multiple owned centers.
• Genea: Australian fertility services group operating IVF clinics and embryology laboratories, including the Genea Biomedx medical device arm. Comparable as a multi-clinic fertility operator with proprietary lab science.
• Inception Fertility: US-based fertility services platform operating clinic brands including The Prelude Network. Directly comparable to Jinxin's HRC subsidiary as a US-focused multi-brand IVF clinic operator.
• New Hope Fertility Center: US fertility clinic group known for mild and natural-cycle IVF protocols. Comparable as a US-based operator competing in the premium IVF segment, similar positioning to HRC.

Regional players

• TFP Fertility: UK-based fertility clinic network owned by a Swedish private equity sponsor, providing IVF and related services. Comparable clinic-network model but serving the UK/European market rather than China or the US.
• Raffles Medical Group: Singapore-listed integrated private healthcare provider offering hospital, specialty, and wellness services. Comparable as a publicly listed regional private healthcare operator with multi-site delivery.

Broad incumbents

• Bangkok Dusit Medical Services (BDMS): Thailand's largest private hospital group, including fertility and reproductive medicine services within its broader tertiary care portfolio. Comparable as a listed Asian healthcare platform that includes fertility among many specialties.
• IHH Healthcare: Malaysia-listed pan-Asian private hospital operator with presence in Malaysia, Singapore, Turkey, and India. Comparable as a multi-country listed hospital platform operating in Asia alongside Jinxin's footprint.
• Apollo Hospitals Enterprise: India-listed private hospital chain offering tertiary care including reproductive medicine and IVF services across India. Comparable as a large listed Asian hospital group with fertility as part of a broader service mix.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/jinxin-fertility-group-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries10 records

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jinxin Fertility